ASEPTIC-MENINGITIS AND INTRAVENOUS IMMUNOGLOBULIN THERAPY - RESPONSE

被引:9
作者
DALAKAS, MC
机构
关键词
D O I
10.7326/0003-4819-122-4-199502150-00021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:316 / 317
页数:2
相关论文
共 5 条
[1]   ASEPTIC GRANULOCYTIC MENINGITIS FOLLOWING TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN [J].
DEVLIEGHERE, FC ;
PEETERMANS, WE ;
VERMYLEN, J .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) :1008-1010
[2]   SOLUBLE HLA CLASS-I AND CLASS-II CONCENTRATIONS IN COMMERCIAL IMMUNOGLOBULIN PREPARATIONS [J].
GROSSEWILDE, H ;
BLASCZYK, R ;
WESTHOFF, U .
TISSUE ANTIGENS, 1992, 39 (02) :74-77
[3]   SELECTIVITY OF RECOGNITION OF VARIABLE (V) REGIONS OF AUTOANTIBODIES BY INTRAVENOUS IMMUNOGLOBULIN (IVIG) [J].
RONDA, N ;
HAURY, M ;
NOBREGA, A ;
COUTINHO, A ;
KAZATCHKINE, MD .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (02) :124-128
[4]   ASEPTIC-MENINGITIS AND INTRAVENOUS IMMUNOGLOBULIN THERAPY [J].
SCRIBNER, CL ;
KAPIT, RM ;
PHILLIPS, ET ;
RICKLES, NM .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (04) :305-306
[5]   ASEPTIC-MENINGITIS ASSOCIATED WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN THERAPY - FREQUENCY AND RISK-FACTORS [J].
SEKUL, EA ;
CUPLER, EJ ;
DALAKAS, MC .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (04) :259-262